To view this email as a web page, click here.
October 1, 2019
 
 
Retinopathy Risk in Lupus Increases With Longer Hydroxychloroquine Use
The incidence of retinopathy among systemic lupus erythematosus (SLE) patents treated with hydroxychloroquine increased with longer treatment duration, but could be predicted by monitoring blood levels of the drug, say researchers writing in Arthritis & Rheumatology this month.
Read more
ADVERTISEMENT
 
FDA Approves New Treatment for Rare Pediatric Vasculitis
The U.S. Food and Drug Administration has approved rituximab (Rituxan, Genentech) for the treatment of granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA) in children 2 years of age and older in combination with glucocorticoids.
Read more
 
Psoriatic Arthritis Quiz: What are the five forms of PsA?
In this installment of our psoriatic arthritis quiz, we focus on features associated with the five types of psoriatic arthritis. Can you identify all types of psoriatic arthritis and address how best to treat each condition?
Read more
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.